BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Skrzydlewska E, Sulkowska M, Wincewicz A, Koda M, Sulkowski S. Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer. World J Gastroenterol 2005; 11(27): 4225-4229 [PMID: 16015694 DOI: 10.3748/wjg.v11.i27.4225]
URL: https://www.wjgnet.com/1007-9327/full/v11/i27/4225.htm
Number Citing Articles
1
Suelem D. Ramalho, Lorena R. F. de Sousa, Marcela C. M. Burger, Maria Inês S. Lima, M. Fátima das G. F. da Silva, João B. Fernandes, Paulo C. Vieira. Evaluation of flavonols and derivatives as human cathepsin B inhibitorNatural Product Research 2015; 29(23): 2212 doi: 10.1080/14786419.2014.1002404
2
Yasuhiro Tsume, Gordon L. Amidon. The Feasibility of Enzyme Targeted Activation for Amino Acid/Dipeptide Monoester Prodrugs of Floxuridine; Cathepsin D as a Potential Targeted EnzymeMolecules 2012; 17(4): 3672 doi: 10.3390/molecules17043672
3
Justyna Szumilo, Franciszek Burdan, Krzysztof Zinkiewicz, Jaroslaw Dudka, Robert Klepacz, Andrzej Dabrowski, Elzbieta Korobowicz. Expression of syndecan-1 and cathepsins D and K in advanced esophageal squamous cell carcinoma.Folia Histochemica et Cytobiologica 2010; 47(4) doi: 10.2478/v10042-008-0012-8
4
Tadeusz Sebzda, Jan Gnus, Barbara Dziadkowiec, Miroslaw Latka, Jakub Gburek. Diagnostic usefulness of selected proteases and acute phase factors in patients with colorectal adenocarcinomaWorld Journal of Gastroenterology 2021; 27(39): 6673-6688 doi: 10.3748/wjg.v27.i39.6673
5
Chih-Ching Wu, Chia-Wei Hsu, Chi-De Chen, Chia-Jung Yu, Kai-Ping Chang, Dar-In Tai, Hao-Ping Liu, Wen-Hui Su, Yu-Sun Chang, Jau-Song Yu. Candidate Serological Biomarkers for Cancer Identified from the Secretomes of 23 Cancer Cell Lines and the Human Protein AtlasMolecular & Cellular Proteomics 2010; 9(6): 1100 doi: 10.1074/mcp.M900398-MCP200
6
Wan-Nan Chen, Jin-Yan Chen, Bo-Yan Jiao, Wan-Song Lin, Yun-Li Wu, Ling-Ling Liu, Xu Lin. Interaction of the Hepatitis B Spliced Protein with Cathepsin B Promotes Hepatoma Cell Migration and InvasionJournal of Virology 2012; 86(24): 13533 doi: 10.1128/JVI.02095-12
7
Doerthe Kuester, Hans Lippert, Albert Roessner, Sabine Krueger. The cathepsin family and their role in colorectal cancerPathology - Research and Practice 2008; 204(7): 491 doi: 10.1016/j.prp.2008.04.010
8
Ziqi Zhang, Pengfei Yue, Tianqi Lu, Yang Wang, Yuquan Wei, Xiawei Wei. Role of lysosomes in physiological activities, diseases, and therapyJournal of Hematology & Oncology 2021; 14(1) doi: 10.1186/s13045-021-01087-1
9
Geum-A Lee, Kyung-Chul Choi, Kyung-A Hwang. Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cellsEnvironmental Toxicology and Pharmacology 2017; 49: 48 doi: 10.1016/j.etap.2016.11.016
10
Yolanda M. Fortenberry, Stephanie Brandal, Ryan C. Bialas, Frank C. Church. Protein C inhibitor regulates both cathepsin L activity and cell-mediated tumor cell migrationBiochimica et Biophysica Acta (BBA) - General Subjects 2010; 1800(6): 580 doi: 10.1016/j.bbagen.2010.03.003
11
Enas A. Hamed, Madeha M. Zakary, Reffat M. Abdelal, Effat M. Abdel Moneim. Vasculopathy in type 2 diabetes mellitus: role of specific angiogenic modulatorsJournal of Physiology and Biochemistry 2011; 67(3): 339 doi: 10.1007/s13105-011-0080-8
12
Mariola Sulkowska, Waldemar Famulski, Andrzej Wincewicz, Tadeusz Moniuszko, Bogusłtaw Kȩdra, Mariusz Koda, Bogdan Zalewski, Marek Baltaziak, Stanislaw Sulkowski. Levels of Ve-Cadherin Increase Independently of Vegf in Preoperative Sera of Patients with Colorectal CancerTumori Journal 2006; 92(1): 67 doi: 10.1177/030089160609200111
13
Kathryn M. Bell, Steven E. Kornguth. Handbook of Biosensors and Biochips2007;  doi: 10.1002/9780470061565.hbb139
14
Jean Breton, Matthew C. Gage, Alastair W. Hay, Jeffrey N. Keen, Christopher P. Wild, Clare Donnellan, John B. C. Findlay, Laura J. Hardie. Proteomic Screening of a Cell Line Model of Esophageal Carcinogenesis Identifies Cathepsin D and Aldo-Keto Reductase 1C2 and 1B10 Dysregulation in Barrett’s Esophagus and Esophageal AdenocarcinomaJournal of Proteome Research 2008; 7(5): 1953 doi: 10.1021/pr7007835